Background Primary Sjogren's Syndrome (pSS) is a classic, immune-mediated, condition of
unknown aetiology characterized by focal lymphocytic infiltration of exocrine glands [1] …

Sjögren's syndrome | British Journal of Hospital Medicine MAG Online Library Skip main
navigation Home Journals AZ Collections MAH Complete MAH Core Health Professionals …

Objectives To develop a score for assessment of patients' symptoms in primary Sjögren's
syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain …

Objective To investigate whether rituximab, an anti–B cell therapy, improves symptoms of
fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). Methods We …

Objectives To explore the relevance of T-follicular-helper (Tfh) and pathogenic peripheral-
helper T-cells (Tph) in promoting ectopic lymphoid structures (ELS) and B-cell mucosa …

OBJECTIVE:: To determine the clinical and laboratory predictors of lymphoma development
in primary Sjögren's syndrome (pSS). METHODS:: Seventy-two patients with pSS were …

Objective To examine whether the B cell tropic γ‐herpesvirus Epstein‐Barr virus (EBV) is
aberrantly expressed in its latent and lytic forms within ectopic lymphoid structures (ELS) in …

Objectives EuroQoL-5 dimension (EQ-5D) is a standardised preference-based tool for
measurement of health-related quality of life and EQ-5D utility values can be converted to …

Background Heterogeneity is a major obstacle to developing effective treatments for patients
with primary Sjögren's syndrome. We aimed to develop a robust method for stratification …

Objectives To compare the effects of rituximab versus placebo on salivary gland ultrasound
(SGUS) in primary Sjögren's syndrome (PSS) in a multicentre, multiobserver phase III trial …